Literature DB >> 12537215

Direct compression of the failing heart reestablishes maximal mechanical efficiency.

Russell A J Carrington1, Yifei Huang, Osamu Kawaguchi, Takeshi Yuasa, Kazuaki Shirota, Donald Martin, Stephen N Hunyor.   

Abstract

BACKGROUND: In failing hearts, homeostatic mechanisms contrive to maximize stroke work and maintain normal arterial blood pressure at the expense of energetic efficiency. In contrast dobutamine reestablishes maximal mechanical efficiency by promoting energetically optimal loading conditions. However, dobutamine also wastefully increases nonmechanical oxygen consumption. We investigated whether direct mechanical cardiac compression would reestablish maximal mechanical efficiency without the oxygen-wasting effect.
METHODS: The pressure-volume relationship and myocardial oxygen consumption were derived in sheep using left ventricular pressure and volume from manometer-tipped and conductance catheters, and coronary flow from Transonics flow probe.
RESULTS: Propranolol hydrochloride and atropine sulfate were administered to reduce ejection fraction to 21% when ventricular elastance fell to 1.35 mm Hg/mL and mechanical efficiency to 79% of maximal. Low-pressure direct mechanical compression of the failing heart restored mechanical efficiency to 94% of maximal and realigned optimal left ventricular end-systolic pressure with operating left ventricular end-systolic pressure without altering nonmechanical oxygen consumption.
CONCLUSIONS: We conclude that direct cardiac compression restores mechanical efficiency to normal maximum without wasting energy on additional nonmechanical activity.

Entities:  

Mesh:

Year:  2003        PMID: 12537215     DOI: 10.1016/s0003-4975(02)04166-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

1.  Left ventricular simulation of cardiac compression: Hemodynamics and regional mechanics.

Authors:  Edgar Aranda-Michel; Lewis K Waldman; Dennis R Trumble
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.